The Mindful and Self-Compassionate Care Program (MASC): Reducing Stress for Caregivers of Persons with Dementia
正念和自我关怀护理计划 (MASC):减轻痴呆症患者护理人员的压力
基本信息
- 批准号:10505172
- 负责人:
- 金额:$ 45.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-01 至 2025-05-31
- 项目状态:未结题
- 来源:
- 关键词:AdherenceAdultAggressive behaviorAgitationAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAnxietyBehaviorBehavioralBehavioral SciencesBenchmarkingBypassCaregiversCaringClinical TrialsCompassionComplexDataDementiaDementia caregiversDissemination and ImplementationDistressEffectivenessEmpathyEnrollmentEnsureFeasibility StudiesFocus GroupsFosteringFundingGeographyGoalsGuiltHealthHealth educationHomeHybridsIndividualInterventionInterviewLanguageLeadLonelinessMassachusettsMeditationMental DepressionModalityModelingMorbidity - disease rateOutcomePatient Self-ReportPatientsPerceptionPersonal SatisfactionPersonsPositioning AttributeProceduresPublic HealthRandomizedRegimenReportingResearchRiskSamplingScienceSelf EfficacyServicesSignal TransductionSingle-Blind StudySocial supportStressStructureSupport GroupsTimeUnited States National Institutes of HealthWell in selfWorkbasebehavior changecare giving burdencare recipientscaregiver stressclinically relevantcollaborative carecommunity centerdementia caredepressive symptomsdesigneffectiveness trialemotion regulationemotional distressethnic minorityevidence baseexperiencefeasibility testingfollow-upimprovedloved onesmindfulnessmortalityphysical conditioningprogramspsychologicracial minorityrecruitsecondary outcomeskillsstress managementtherapy developmentuptakevideo deliveryvirtualvirtual deliveryweb platform
项目摘要
PROJECT SUMMARY:
Within a 3-year R01 we will use the NIH stage model and principles from the Science of Behavioral Change to develop,
optimize and establish proof of concept for the Mindful, Self-Compassionate Care Program (MASC) for stressed caregivers
of persons with ADRD with challenging behaviors. In aim 1, we will use qualitative focus groups to develop MASC (NIH
stage 1A; up to 30 caregivers; n=4 groups). In aim 2, we will optimize MASC and conduct an open pilot with exit interviews
to explore feasibility benchmarks, target engagement and signal of improvement in stress, depression, anxiety and well-
being (NIH stage 1A; up to 10 caregivers; n=1 group). In aim 3, we will conduct a pilot RCT of MASC versus a Health
Education control to establish feasibility benchmarks and preliminary efficacy and explore evidence for potential
mechanisms of improvement through the proposed mechanistic targets (N=80/c0 completers). MASC combines evidence-
based skills from mindfulness programs, self-compassion programs, and behavioral management programs. MASC
structure and components are designed to facilitate uptake, skill practice, and sustainability of improvements. MASC has 6
sessions and is delivered virtually in groups. MASC has an associated web platform that facilitates skills practice and is
available to caregivers after the group ends. Our guiding hypothesis is that MASC skills of mindfulness, self-compassion,
and behavioral management will interact and lead to decreased stress, depression and anxiety and improved well-being,
through decreased loneliness, increased caregiver self-efficacy, social support, mindfulness, self-compassion, compassion
and improved relationship quality. Our team is well positioned to conduct this study with specific experience in mindfulness
and self-compassion programs; intervention development, feasibility testing and clinical trials; ADRD caregivers;
recruitment of national, geographically diverse samples. At the end of the 3-year period of this R01 we will have clear
evidence of the feasibility of study procedures, randomization, acceptability, credibility, adherence, ability to retain and
recruit as well as its proof of concepts in reducing stress in caregivers of people with ADRD and proposed mechanisms.
Results from this R01 study will be used to apply for funding to conduct a fully powered hybrid efficacy-effectiveness RCT.
The goal is dissemination and implementation of MASC to reduce stress, among all in need caregivers of persons with
ADRD.
项目摘要:
在3年的R01中,我们将使用NIH阶段模型和行为改变科学的原则来发展,
为紧张的护理人员优化并建立正念,自招的护理计划(MASC)的概念验证
具有充满挑战行为的ADRD的人。在AIM 1中,我们将使用定性焦点小组开发MASC(NIH
第1A阶段;多达30名照料者; n = 4组)。在AIM 2中,我们将优化MASC并进行开放式飞行员,并进行退出访谈
探索可行性基准,目标参与度以及压力,抑郁,焦虑和良好的改善信号
存在(NIH 1A阶段;最多10名护理人员; n = 1组)。在AIM 3中,我们将进行MASC与健康的飞行员RCT
教育控制以建立可行性基准和初步疗效,并探讨潜在的证据
通过提出的机械目标改进的机制(n = 80/c0完成者)。 MASC结合了证据 -
正念计划,自我同情计划和行为管理计划的基于技能。 Masc
结构和组件旨在促进采用,技能实践和改进的可持续性。 MASC有6个
会议,几乎分组交付。 MASC拥有一个相关的网络平台,可促进技能实践,并且是
小组结束后,护理人员可以使用。我们的指导假设是正念,自我同情的MASC技能
行为管理将相互作用,并导致压力减轻,抑郁和焦虑以及改善的幸福感,
通过减少孤独感,增加照顾者的自我效能感,社会支持,正念,自我同情,同情心
并改善了关系质量。我们的团队在正念方面具有特定经验的精神,可以进行这项研究
和自我同情计划;干预开发,可行性测试和临床试验; ADRD护理人员;
招募国家地理不同样本。在此R01的3年结束时,我们将有清晰的
研究程序,随机化,可接受性,信誉,依从性,保留能力和
招募及其在减少ADRD和拟议机制的人的护理人员压力方面的概念证明。
这项R01研究的结果将用于申请资金以进行全功率的混合功效效果RCT。
目的是传播和实施MASC以减轻压力
adrd。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Christine S Ritchie其他文献
Intervention for the management of neuropsychiatric symptoms to reduce caregiver stress: Protocol for the Mindful and Self-compassion Care (MASC) intervention for caregivers of persons living with dementia (Preprint)
管理神经精神症状以减轻护理人员压力的干预措施:针对痴呆症患者护理人员的正念和自我同情护理 (MASC) 干预方案(预印本)
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:1.7
- 作者:
Aniyah Travis;Arden O’Donnell;Natalia Giraldo;Sarah M. Stone;Daniel Torres;Shelley R Adler;A. Vranceanu;Christine S Ritchie - 通讯作者:
Christine S Ritchie
Christine S Ritchie的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Christine S Ritchie', 18)}}的其他基金
Bridging the Science-to-Service Gap in Aging Care: Prevention, Optimization and Living Well with Persistent or Serious Illnesses
缩小老年护理中科学与服务的差距:持续或严重疾病的预防、优化和健康生活
- 批准号:
10638577 - 财政年份:2023
- 资助金额:
$ 45.46万 - 项目类别:
Addressing the chronic pain-early cognitive decline comorbidity among older adults; The Active Brains study
解决老年人慢性疼痛-早期认知能力下降的合并症;
- 批准号:
10370093 - 财政年份:2022
- 资助金额:
$ 45.46万 - 项目类别:
Addressing the chronic pain epidemic among older adults in underserved community center; The GetActive+ study.
解决服务不足的社区中心老年人中流行的慢性疼痛问题;
- 批准号:
10536153 - 财政年份:2022
- 资助金额:
$ 45.46万 - 项目类别:
Addressing the chronic pain-early cognitive decline comorbidity among older adults; The Active Brains study
解决老年人慢性疼痛-早期认知能力下降的合并症;
- 批准号:
10558586 - 财政年份:2022
- 资助金额:
$ 45.46万 - 项目类别:
Addressing the chronic pain epidemic among older adults in underserved community center; The GetActive+ study (McDermott-Career Enhancement Supplement)
解决服务不足的社区中心老年人中流行的慢性疼痛问题;
- 批准号:
10789061 - 财政年份:2022
- 资助金额:
$ 45.46万 - 项目类别:
Palliative Care Research Cooperative Group (PCRC): Investigator Development Center
姑息治疗研究合作小组 (PCRC):研究者发展中心
- 批准号:
10438802 - 财政年份:2013
- 资助金额:
$ 45.46万 - 项目类别:
相似国自然基金
成人型弥漫性胶质瘤患者语言功能可塑性研究
- 批准号:82303926
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
MRI融合多组学特征量化高级别成人型弥漫性脑胶质瘤免疫微环境并预测术后复发风险的研究
- 批准号:82302160
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
成人免疫性血小板减少症(ITP)中血小板因子4(PF4)通过调节CD4+T淋巴细胞糖酵解水平影响Th17/Treg平衡的病理机制研究
- 批准号:82370133
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
SMC4/FoxO3a介导的CD38+HLA-DR+CD8+T细胞增殖在成人斯蒂尔病MAS发病中的作用研究
- 批准号:82302025
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
融合多源异构数据应用深度学习预测成人肺部感染病原体研究
- 批准号:82302311
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Executive Functioning and Physical Activity in Adolescents At-Risk for Type 2 Diabetes
有 2 型糖尿病风险的青少年的执行功能和体力活动
- 批准号:
10667026 - 财政年份:2022
- 资助金额:
$ 45.46万 - 项目类别:
PRIME: PrEP Intervention for people who Inject MEthamphetamine
PRIME:针对注射甲基苯丙胺患者的 PrEP 干预
- 批准号:
10223260 - 财政年份:2020
- 资助金额:
$ 45.46万 - 项目类别:
PRIME: PrEP Intervention for people who Inject MEthamphetamine
PRIME:针对注射甲基苯丙胺患者的 PrEP 干预
- 批准号:
10655538 - 财政年份:2020
- 资助金额:
$ 45.46万 - 项目类别:
PRIME: PrEP Intervention for people who Inject MEthamphetamine
PRIME:针对注射甲基苯丙胺患者的 PrEP 干预
- 批准号:
10424546 - 财政年份:2020
- 资助金额:
$ 45.46万 - 项目类别:
PRIME: PrEP Intervention for people who Inject MEthamphetamine
PRIME:针对注射甲基苯丙胺患者的 PrEP 干预
- 批准号:
10054139 - 财政年份:2020
- 资助金额:
$ 45.46万 - 项目类别: